Sponsor our #PostdocFutures24 event to showcase your organisation at our careers fair exhibition, with the chance to connect with postdoctoral researchers looking to take the next step in their careers.

Register interest to learn more forms.office.com/e/mW8vmL02RC

Junior Group leader at CRUK Cambridge Institute, Giulia Biffi has been making her mark in pancreatic cancer research. Her work raises questions about cancer-associated fibroblasts and their potential to offer new therapeutic opportunities for patients.
Read the article 👉bit.ly/4bvXauH

Looking to showcase your work to the international #BrainTumour community at #CRUKBrain24 ?🧠

There’s only 2 weeks left to submit your abstract & join Karen Vousden (The Crick), Arnold Kriegstein (@UCSF) & Claudia Kleinman (@mcgillu) as part of the programme: bit.ly/3NvIcLK

Join American Cancer Society Science and Innovation at Cancer Research UK and National Cancer Institute for the first-ever #PrevConf24 to discuss discovery biology, translational & behavioral science, population & implementation research. Learn more and register here: bit.ly/3u7x9BX

🎉Congratulations to Dr Alexis B Webb, our Research Programme Manager, for the paper published in The Lancet Oncology on surrogate endpoints in #CancerScreening trials.

Philip E. Castle, Ph.D. | Professor Usha Menon | Peter Sasieni

Read the paper: bit.ly/44nKG69

Registrations are open for our #EDxConf24 . Join us in San Francisco this year on 22-24 October to connect with the global cancer early detection community.

Get your ticket now👉bit.ly/3woQArc

Canary Center at Stanford | OHSU Knight Cancer Institute

All cancer postdocs welcome at #PostdocFutures24

Attendees can book a 1:1 discussion with a CRUK Research Careers team member for advice on our funding, fellowship and training opportunities.

Tickets refundable after attendance, register by 24 May bit.ly/421tfqU

You’re all invited to share your passion and your perspective on research with us 📩

Send us your images today to get shortlisted for our monthly picks – let your photos do the talking!

T&Cs apply: cancerresearchuk.org/terms-and-cond…

#ResearchIsBeautiful

Ton Schumacher is closing #CancerHostTI24 discussing neoantigens and neoadjuvant therapy. With his research group he created technologies to dissect T cell responses in cancer and contributed to the development of adoptive T cell therapies and neoadjuvant cancer immunotherapy.

Cecilia Johansson is presenting at #CancerHostTI24 on type I interferons induced upon respiratory viral infection impair lung metastasis. Her lab studies the generation and regulation of immunity via cellular crosstalk in the lung during viral infections during cancer. (NC)

Kienan Savage starts exploring the systemic immune system and signals governing immune responses to cancer. Kienan works to understand the cellular DNA damage response/repair systems and how defects in these pathways contribute to cancer development, progression and response to…

Fantastic session highlighting the breadth of cancer immunology questions being addressed by early-stage researchers at the future leaders lightning talk session at #CancerHostTI24 (NC) ⚡️⚡️

Now we’re onto what is often my favourite part of modern research meetings, the ECR lightning talks: a quick dip into lots of fantastic topics. James Reading hosting our featured future superstars. #CancerHostTI24

Evangelos Giampazolias seeks to understand the signals that make cancer a visible threat to the immune system so is decoding the host-microbiome interactions that regulate cancer immunity. (NC)
#CancerHostTI24 CRUK Manchester Institute

Jessica Strid is presenting on the role of eosinophils in skin homeostasis, inflammation and carcinogenesis at #CancerHostTI24

We’re now hearing from #ClinicianScientist Sean Lim on understanding and developing novel cancer immunotherapies, in particular, immunostimulatory antibodies.

#CancerHostTI24 University of Southampton

Steve Pollard is telling us about his translational research focussing on the creation of novel gene therapies to tackle cancers of unmet need and the biotech company he’s founded to move this forward into full clinical development. (NC)

#CancerHostTI24 | The University of Edinburgh

Back from lunch at #CancerHostTI24 and moving onto an exploration of the exciting developments in anticancer immune responses beyond those mediated by T cells, chaired by Cecilia Johansson. (NC)

Cecilia Johansson | Imperial College London